Li D - Search Results

1

Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.

Tanaka M, Chang P, Li Y, Li D, Overman M, Maru DM, Sethi S, Phillips J, Bland GL, Abbruzzese JL, Eng C. Tanaka M, et al. Among authors: li d, li y. Clin Cancer Res. 2011 Jul 1;17(13):4531-40. doi: 10.1158/1078-0432.CCR-10-0763. Epub 2011 May 6. Clin Cancer Res. 2011. PMID: 21551253

2

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.

Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M, Abbruzzese JL. Li D, et al. Mutat Res. 2002 Jan 15;513(1-2):37-48. doi: 10.1016/s1383-5718(01)00291-1. Mutat Res. 2002. PMID: 11719088

3

Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.

Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, Hassan MM, Li D. Firozi PF, et al. Among authors: li d. Carcinogenesis. 2002 Feb;23(2):301-6. doi: 10.1093/carcin/23.2.301. Carcinogenesis. 2002. PMID: 11872636

4

Characterization of a major aromatic DNA adduct detected in human breast tissues.

Li D, Wang M, Firozi PF, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH, DiGiovanni J. Li D, et al. Environ Mol Mutagen. 2002;39(2-3):193-200. doi: 10.1002/em.10063. Environ Mol Mutagen. 2002. PMID: 11921189

5

Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer.

Li D, Walcott FL, Chang P, Zhang W, Zhu J, Petrulis E, Singletary SE, Sahin AA, Bondy ML. Li D, et al. Cancer Res. 2002 Aug 15;62(16):4566-70. Cancer Res. 2002. PMID: 12183407

6

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Hassan MM, et al. Among authors: li d. Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331

7

Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.

Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S. Li D, et al. Clin Cancer Res. 2003 Mar;9(3):991-7. Clin Cancer Res. 2003. PMID: 12631597

8

Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.

Zhu J, Chang P, Bondy ML, Sahin AA, Singletary SE, Takahashi S, Shirai T, Li D. Zhu J, et al. Among authors: li d. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):830-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504191

9

Pancreatic cancer.

Li D, Xie K, Wolff R, Abbruzzese JL. Li D, et al. Lancet. 2004 Mar 27;363(9414):1049-57. doi: 10.1016/S0140-6736(04)15841-8. Lancet. 2004. PMID: 15051286 Review.

10

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.

Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. Asano T, et al. Among authors: li d. Oncogene. 2004 Nov 11;23(53):8571-80. doi: 10.1038/sj.onc.1207902. Oncogene. 2004. PMID: 15467756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,158 results

Search Page

Filters